Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada
· Delayed Price · Currency is CAD 3.100
0.00 (0.00%)
At close: Mar 9, 2026
Medexus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 14.98 | 23.97 | 5.26 | 13.07 | 10.02 | 18.7 | Upgrade
|
| Cash & Short-Term Investments | 14.98 | 23.97 | 5.26 | 13.07 | 10.02 | 18.7 | Upgrade
|
| Cash Growth | 77.41% | 356.19% | -59.79% | 30.45% | -46.44% | 257.42% | Upgrade
|
| Accounts Receivable | 11.77 | 13.17 | 23.87 | 21.97 | 13.39 | 18.4 | Upgrade
|
| Other Receivables | 0.07 | 0.14 | 0.16 | 0.41 | 1.02 | 0.43 | Upgrade
|
| Receivables | 11.83 | 13.31 | 24.03 | 22.38 | 14.41 | 18.83 | Upgrade
|
| Inventory | 31.3 | 39.82 | 36.72 | 22.85 | 21.35 | 14.67 | Upgrade
|
| Prepaid Expenses | 11.86 | 3.1 | 4.19 | 12.38 | 2.06 | 4.71 | Upgrade
|
| Other Current Assets | - | 0.38 | 2.3 | 2.3 | 1.28 | 1.67 | Upgrade
|
| Total Current Assets | 69.97 | 80.57 | 72.5 | 72.97 | 49.11 | 58.57 | Upgrade
|
| Property, Plant & Equipment | 0.46 | 0.69 | 0.78 | 0.9 | 1.22 | 0.8 | Upgrade
|
| Goodwill | 10.22 | 10 | 10.28 | 10.28 | 10.69 | 10.65 | Upgrade
|
| Other Intangible Assets | 64.78 | 71.6 | 64.14 | 70.37 | 76.57 | 76.36 | Upgrade
|
| Long-Term Deferred Tax Assets | 9.56 | 8.98 | 8.04 | 6.81 | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 1.64 | 2.13 | Upgrade
|
| Total Assets | 154.98 | 171.84 | 155.73 | 161.33 | 139.23 | 148.51 | Upgrade
|
| Accounts Payable | 43.38 | 5.73 | 7.75 | 10.16 | 12.05 | 14.86 | Upgrade
|
| Accrued Expenses | - | 35.29 | 35.48 | 23.26 | 17.13 | 12.47 | Upgrade
|
| Current Portion of Long-Term Debt | 6.99 | 36.79 | 15.74 | 42.71 | 15.05 | 10.57 | Upgrade
|
| Current Portion of Leases | 0.21 | 0.19 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | 2.34 | 1.37 | 1.32 | 1.18 | 0.03 | 0.51 | Upgrade
|
| Other Current Liabilities | 9.48 | 17.94 | 5.94 | 6.19 | 3.86 | 1.53 | Upgrade
|
| Total Current Liabilities | 62.4 | 97.31 | 66.23 | 83.5 | 48.11 | 39.94 | Upgrade
|
| Long-Term Debt | 18.08 | - | 33.61 | 26.78 | 39.03 | 34.09 | Upgrade
|
| Long-Term Leases | 0.08 | 0.2 | 0.54 | 0.6 | 0.78 | 0.21 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 1.52 | 2.65 | Upgrade
|
| Other Long-Term Liabilities | 22.22 | 22.19 | 25.03 | 28.01 | 31.99 | 53.61 | Upgrade
|
| Total Liabilities | 102.77 | 119.7 | 125.41 | 138.88 | 121.43 | 130.5 | Upgrade
|
| Common Stock | 96.22 | 96.1 | 76.39 | 69.01 | 68.69 | 66.69 | Upgrade
|
| Additional Paid-In Capital | 11.55 | 12.01 | 12.01 | 11.31 | 10.38 | 9.5 | Upgrade
|
| Retained Earnings | -61.71 | -62 | -64.24 | -64.03 | -65.25 | -62.37 | Upgrade
|
| Comprehensive Income & Other | 6.15 | 6.03 | 6.17 | 6.16 | 3.97 | 4.2 | Upgrade
|
| Shareholders' Equity | 52.21 | 52.14 | 30.32 | 22.45 | 17.79 | 18.02 | Upgrade
|
| Total Liabilities & Equity | 154.98 | 171.84 | 155.73 | 161.33 | 139.23 | 148.51 | Upgrade
|
| Total Debt | 25.35 | 37.18 | 49.9 | 70.08 | 54.86 | 44.87 | Upgrade
|
| Net Cash (Debt) | -10.38 | -13.21 | -44.64 | -57.01 | -44.84 | -26.17 | Upgrade
|
| Net Cash Per Share | -0.33 | -0.50 | -2.00 | -2.78 | -2.26 | -1.72 | Upgrade
|
| Filing Date Shares Outstanding | 32.3 | 32.26 | 24.46 | 20.25 | 19.95 | 19.17 | Upgrade
|
| Total Common Shares Outstanding | 32.31 | 32.26 | 24.46 | 20.18 | 19.95 | 19.17 | Upgrade
|
| Working Capital | 7.57 | -16.74 | 6.27 | -10.53 | 1 | 18.63 | Upgrade
|
| Book Value Per Share | 1.62 | 1.62 | 1.24 | 1.11 | 0.89 | 0.94 | Upgrade
|
| Tangible Book Value | -22.79 | -29.46 | -44.09 | -58.21 | -69.46 | -69 | Upgrade
|
| Tangible Book Value Per Share | -0.71 | -0.91 | -1.80 | -2.88 | -3.48 | -3.60 | Upgrade
|
| Machinery | - | 1.26 | 1.12 | 1.07 | 1.06 | 0.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.